BRAF MUTATION-RELATED TUMORS
Clinical trials for BRAF MUTATION-RELATED TUMORS explained in plain language.
Never miss a new study
Get alerted when new BRAF MUTATION-RELATED TUMORS trials appear
Sign up with your email to follow new studies for BRAF MUTATION-RELATED TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets Hard-to-Treat cancers: early trial recruits 554 patients
Disease control Recruiting nowThis study tests an experimental oral drug called S241656 (BDTX-4933) in people with advanced solid tumors that have certain genetic changes (KRAS, BRAF, or other RAS/MAPK mutations). The trial has two parts: first, finding a safe dose, then testing how well it works alone or wit…
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for deadly thyroid cancer? drug combo tested before surgery
Disease control Recruiting nowThis early-phase trial is testing whether giving a combination of two drugs (XL092 and cemiplimab) before surgery can help people with a rare and fast-growing thyroid cancer called anaplastic thyroid cancer. The study will enroll 12 participants to see if the treatment is safe an…
Matched conditions: BRAF MUTATION-RELATED TUMORS
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC